Rotating your injection site each week is one of the simplest things you can do to avoid injection site reactions and make sure your medication absorbs the way it should
That statement does not include enrollment dates, participation logs, or weight outcomes

Current UK professional guidance emphasises: Patients should inform their surgical team and anaesthetist that they are taking a GLP-1 medication as soon as surgery is planned Healthcare professionals should specifically ask about GLP-1 use during preoperative assessment, as patients may not recognise these medications as relevant to their surgery The decision to continue or pause GLP-1 therapy should be made on an individual risk-based assessment , considering the type of surgery, the specific GLP-1 agent, dose escalation status, presence of gastrointestinal symptoms, and the patient's clinical circumstances Many patients can safely continue GLP-1 medications perioperatively with appropriate precautions, while those at higher risk may benefit from temporary cessation The Summary of Product Characteristics (SmPC) for GLP-1 medications notes the delayed gastric emptying effect, which anaesthetists consider when planning perioperative care

The sweet spot is usually eating enough to support energy, protein intake, digestion, and muscle preservation while still allowing steady weight loss
The lack of a PRP-only group also limits differentiation between independent and combined treatment effects
Patients are rationing doses to cut costs GLP-1 medications work by mimicking a hormone in the body that helps regulate appetite and blood sugar